Ophirex Publishes Phase 2 BRAVIO Varespladib Data
Durham, North Carolina — September 22, 2026 Ophirex announced publication of results from the Phase 2 BRAVIO clinical trial...
India
Advertisement
Lakewood-Amedex Highlights Nu-3 Against Antibiotic Resistance
SARASOTA, Fla., July 22, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced new preclinical resistance data supporting its lead antimicrobial candidate...
Co-Diagnostics Targets India TB Diagnostics with PCR Pro Studies
SALT LAKE CITY, July 22, 2026 Co-Diagnostics, Inc. has announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd.,...
Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets
MUMBAI, India & NAPLES, Fla., June 26, 2026 Lupin Limited announced that it has received tentative approval from the...
Emcure Partners with Novo Nordisk to Bring Semaglutide to India
Bengaluru, November 10, 2025 — Global diabetes-care leader Novo Nordisk India has entered into a strategic partnership with Emcure...
Advertisement
